Secondary solid tumors after allogeneic hematopoietic SCT in Japan.

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a life-saving procedure.
• Secondary solid tumors are a known long-term complication post-transplantation.
• Understanding specific risks in Japanese populations is crucial for tailored surveillance.

Purpose of the Study:

• To determine the incidence and identify risk factors for secondary solid tumors in Japanese patients following allo-HSCT.
• To compare these findings with previously reported data from Western countries.
• To assess the impact of secondary solid tumors on overall survival (OS).

Main Methods:

• Retrospective analysis of 2,062 patients who underwent allo-HSCT between 1984 and 2005 in Japan.
• Identification of patients who developed secondary solid tumors post-transplantation.
• Multivariate analysis to identify significant risk factors, including chronic graft-versus-host disease (GVHD) and primary disease type.

Main Results:

• A cumulative incidence of 2.4% for solid tumors at 10 years post-allo-HSCT was observed.
• The risk of developing tumors was 2.16-fold higher than in the general population, with significantly elevated risks for skin, oral cavity, and esophageal cancers.
• Chronic GVHD and a history of malignant lymphoma were associated with a higher risk of secondary solid tumors.

Conclusions:

• The incidence and risk factors for secondary solid tumors in Japanese allo-HSCT recipients are comparable to Western populations.
• Specific tumor types, including skin, oral, and esophageal cancers, show a notable increased risk.
• Early detection strategies are essential for improving overall survival in patients post-allo-HSCT.